Haemonetics (HAE) Tops Q3 EPS by 3c; Sees FY17 Outlook at High End of Range
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| HAEMONETICS CORPORATION (NYSE: HAE) | Delayed: 125.77 +5.49 (4.56%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $120.28 | 52 Week High | $39.41 | |||
| Open | $122.16 | 52 Week Low | $25.98 | |||
| Day High | $125.99 | P/E | 177.14 | |||
| Day Low | $121.26 | EPS | $0.71 | |||
| Volume | 187,791 | |||||
